Sanofi (FRA:SNW2)

Market Cap	98.50B
Revenue (ttm)	45.74B
Net Income (ttm)	9.13B
Shares Out	n/a
EPS (ttm)	7.36
PE Ratio	10.79
Forward PE	9.94
Dividend	1.42 (3.60%)
Ex-Dividend Date	May 9, 2025

Volume	n/a
Average Volume	184
Open	39.20
Previous Close	39.20
Day's Range	39.20 - 39.80
52-Week Range	39.20 - 54.50
Beta	n/a
RSI	36.11
Earnings Date	Oct 24, 2025

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; inf...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 82,878
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SNW2

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.